In particular, this resistance was linked to the regulation of IP-L, as co-silencing of CML and IP-L negated the facilitation of TMV infection caused by CML silencing. This evidence concerns the gene PHLDA2 and chronic myelogenous leukemia, BCR-ABL1 positive.